Alternative splicing and disease

被引:389
|
作者
Tazi, Jamal [2 ]
Bakkour, Nadia [2 ]
Stamm, Stefan [1 ]
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[2] Univ Montpellier 2, Inst Mol Genet, CNRS, F-34095 Montpellier 5, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2009年 / 1792卷 / 01期
关键词
Alternative splicing; Disease; Splicing code; Mutation; SPINAL MUSCULAR-ATROPHY; COLI APC GENE; STERIC-BLOCK OLIGONUCLEOTIDES; AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE-SPECIFIC EXPRESSION; RNA SECONDARY STRUCTURE; MESSENGER-RNA; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; TAU GENE;
D O I
10.1016/j.bbadis.2008.09.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Almost all protein-coding genes are spliced and their majority is alternatively spliced. Alternative splicing is a key element in eukaryotic gene expression that increases the coding capacity of the human genome and an increasing number of examples illustrates that the selection of wrong splice sites causes human disease. A fine-tuned balance of factors regulates splice site selection. Here, we discuss well-studied examples that show how a disturbance of this balance can cause human disease. The rapidly emerging knowledge of splicing regulation now allows the development of treatment options. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 50 条
  • [21] Predicting functional riboSNitches in the context of alternative splicing
    Ramya, G.
    Mitra, Abhijit
    Vinod, P. K.
    GENE, 2022, 837
  • [22] Oxidants induce alternative splicing of α-synuclein: Implications for Parkinson's disease
    Kalivendi, Shasi V.
    Yedlapudi, Deepthi
    Hillard, Cecilia J.
    Kalyanaraman, B.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (03) : 377 - 383
  • [23] Computational approaches for detecting disease-associated alternative splicing events
    Liu, Jiashu
    Lin, Cui-Xiang
    Zhang, Xiaoqi
    Li, Zongxuan
    Huang, Wenkui
    Liu, Jin
    Guan, Yuanfang
    Li, Hong-Dong
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (03)
  • [24] Alternative RNA Splicing in Fatty Liver Disease
    Wu, Panyisha
    Zhang, Moya
    Webster, Nicholas J. G.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [25] SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
    Shehadeh, Lina A.
    Yu, Kristine
    Wang, Liyong
    Guevara, Alexandra
    Singer, Carlos
    Vance, Jeffery
    Papapetropoulos, Spyridon
    PLOS ONE, 2010, 5 (02):
  • [26] Genome-wide profiling of alternative splicing in Alzheimer's disease
    Lai, Mitchell K. P.
    Esiri, Margaret M.
    Tan, Michelle G. K.
    GENOMICS DATA, 2014, 2 : 290 - 292
  • [27] Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
    Ren, Pingping
    Lu, Luying
    Cai, Shasha
    Chen, Jianghua
    Lin, Weiqiang
    Han, Fei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Identification of RBMX as a splicing regulator in Parkinsonian mimetic induced alternative splicing of a-synuclein
    Thonda, Swaroop
    Vinnakota, Ravali L.
    Kona, Swathi V.
    Kalivendi, Shasi V.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2022, 1865 (04):
  • [29] Alternative splicing of RAGE: roles in biology and disease
    Kalea, Anastasia Z.
    Schmidt, Ann Marie
    Hudson, Barry I.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 2756 - 2770
  • [30] Splicing: is there an alternative contribution to Parkinson’s disease?
    Valentina La Cognata
    Velia D’Agata
    Francesca Cavalcanti
    Sebastiano Cavallaro
    neurogenetics, 2015, 16 : 245 - 263